Association between two polymorphisms in the HLA-G gene and angiographic coronary artery disease

被引:10
作者
Boiocchi, Chiara [1 ]
Bozzini, Sara [2 ]
Zorzetto, Michele [3 ]
Pelissero, Gabriele [4 ]
Cuccia, Mariaclara [1 ]
Falcone, Colomba [2 ,5 ]
机构
[1] Univ Pavia, Dept Genet & Microbiol, Immunogenet Lab, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy
[2] Univ Pavia, Fdn IRCCS Policlin San Matteo, Interdept Ctr Res Mol Med CIRMC, I-27100 Pavia, Italy
[3] Univ Pavia, Fdn IRCCS Policlin San Matteo, Lab Biochem & Genet, Inst Resp Dis, I-27100 Pavia, Italy
[4] Sci Direct IRCCS Policlin San Donato, Milan, Italy
[5] Pavia Univ Hosp, Ist Cura Citta, Dept Cardiol, Pavia, Italy
关键词
human leukocyte antigen G; polymorphisms; coronary artery disease; immunogenetics; HUMAN NK CELLS; T-LYMPHOCYTES; DELETION POLYMORPHISM; RHEUMATOID-ARTHRITIS; INFLAMMATORY DISEASE; MULTIPLE-SCLEROSIS; ULCERATIVE-COLITIS; PERIPHERAL-BLOOD; CROHNS-DISEASE; G MOLECULES;
D O I
10.3892/mmr.2012.825
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Atherosclerosis and related complications still represent the major cause of morbidity and mortality in industrialized countries. Therefore, it is particularly important to investigate the molecules involved in cardiac inflammation. Evidence exists showing that the human leukocyte antigen-G (HLA-G) gene tissue expression and related protein physiological significance is influenced by two polymorphisms, rs16375 and rs1632933. In this study, allelic, genotypic and haplotypic frequencies of a 14-bp insertion/deletion (Ins/Del) (rs16375) and of rs1632933 polymorphisms of the HLA-G gene were investigated in 664 patients with coronary artery disease (CAD) and 345 matched controls by polymerase chain reaction (PCR)-restriction fragment length polymorphism analysis and real-time PCR. The frequency of the Ins/Ins genotype was significantly higher in patients with CAD compared to the controls (P=0.018). After analysis of confounding variables, the results showed that the homozygous Ins/Ins was significantly and independently associated with the presence of angiographic CAD (odds ratio 2.09, 95% confidence interval 1.10-4.02, P=0.03). Our data demonstrate a new risk factor for this multifactorial inflammatory disease.
引用
收藏
页码:1141 / 1145
页数:5
相关论文
共 43 条
[1]   HLA-G and NK receptor are expressed in psoriatic skin - A possible pathway for regulating infiltrating T cells? [J].
Aractingi, S ;
Briand, N ;
Le Danff, C ;
Viguier, M ;
Bachelez, H ;
Michel, L ;
Dubertret, L ;
Carosella, ED .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (01) :71-77
[2]   HLA-G suppresses proliferation of CD4+ T-lymphocytes [J].
Bainbridge, DRJ ;
Ellis, SA ;
Sargent, IL .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2000, 48 (01) :17-26
[3]  
Baricordi Olavio R., 2008, Inflammation & Allergy Drug Targets, V7, P67, DOI 10.2174/187152808785107615
[4]   HLA-G and HLA-E: fundamental and pathophysiological aspects [J].
Carosella, ED ;
Paul, P ;
Moreau, P ;
Rouas-Freiss, N .
IMMUNOLOGY TODAY, 2000, 21 (11) :532-534
[5]   HLA-G: from biology to clinical benefits [J].
Carosella, Edgardo D. ;
Moreau, Philippe ;
LeMaoult, Joeel ;
Rouas-Freiss, Nathalie .
TRENDS IN IMMUNOLOGY, 2008, 29 (03) :125-132
[6]   The class IHLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G [J].
Cirulli, V ;
Zalatan, J ;
McMaster, M ;
Prinsen, R ;
Salomon, DR ;
Ricordi, C ;
Torbett, BE ;
Meda, P ;
Crisa, L .
DIABETES, 2006, 55 (05) :1214-1222
[7]   Apoptosis of antigen-specific T lymphocytes upon the engagement of CD8 by soluble HLA class I molecules is Fas ligand/Fas mediated:: Evidence for the involvement of p56lck calcium calmodulin kinase II, and calcium-independent protein kinase C signaling pathways and for NF-κB and NF-AT nuclear translocation [J].
Contini, P ;
Ghio, M ;
Merlo, A ;
Poggi, A ;
Indiveri, F ;
Puppo, F .
JOURNAL OF IMMUNOLOGY, 2005, 175 (11) :7244-7254
[8]   Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts [J].
Crisa, L ;
McMaster, MT ;
Ishii, JK ;
Fisher, SJ ;
Salomon, DR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (02) :289-298
[9]  
Dorling A, 2000, EUR J IMMUNOL, V30, P586, DOI 10.1002/1521-4141(200002)30:2<586::AID-IMMU586>3.3.CO
[10]  
2-P